Download LUNG CANCER 2016:

CME Information
COURSE DESCRIPTION
This one-day symposium will provide a comprehensive
update on advances in the management of patients
with lung cancer. Lung cancer is the leading cause
of cancer-related deaths in the United States, with
over 225,000 people being diagnosed last year.
Recommendations for CT screening in lung cancer
have been updated, newer diagnostic and local
treatment modalities are available, significant
advances have been made in immunotherapeutic
approaches, and exciting new agents are being
developed in EGFR-mutant and ALK-rearranged
lung cancer. This symposium will review all of the
recent advances in a highly interactive case-based
discussion format, supported by didactic lectures by
thought leaders and other well-respected faculty in
each field.
LEARNING OBJECTIVES
TARGET AUDIENCE
•
Utilize current USPTF/ACS guidelines for appropriate
screening for lung cancer in high risk individuals with
an emphasis on smoking cessation
•
Apply ASTRO/IASLC guidelines to select appropriate
patients for treatment with stereotactic radiosurgical
techniques or proton beam therapy
This conference is intended for pulmonologists, medical
and radiation oncologists, thoracic surgeons, interventional
radiologists, oncology nurses, radiation therapy
technologists, advanced practice clinicians, residents
and fellows.
•
Apply the 7th edition of the AJCC staging system and
utilize appropriate staging modalities to arrive at the
correct stage
•
Review radiation therapy options, recommend the
appropriate radiation treatment method(s) and educate
patients accordingly.
•
Review controversial issues surrounding the role of
surgery such as in small cell lung cancer, N2 nodepositive non-small cell lung cancer, or sub-lobar
resections and perform appropriate patient selection
for the right procedure for optimal oncologic outcomes
•
Explain the initial immunotherapy clinical trial data
in non-small cell lung cancer, learn to recognize the
response profile and side effects of these medications
and manage immune-mediated complications
•
Analyze malignant tumors genomically with novel
technologies such as liquid biopsies and select
therapies using a targeted approach when clinical trial
data indicate efficacy, with focus on newer EGFR and
ALK inhibitors
•
Elucidate on the management of patients with NSCLC
tumors harboring rare mutations and with brain or
leptomeningeal metastases
CME ACCREDITATION
MedStar Georgetown University Hospital is accredited by the
Accreditation Council for Continuing Medical Education to
provide continuing medical education for physicians.
CREDIT DESIGNATION
MedStar Georgetown University Hospital designates this live
activity for a maximum of 6.75 AMA PRA Category 1 CreditsTM.
Physicians should claim only the credit commensurate with
the extent of their participation in the activity.
LUNG CANCER 2016: Progress and Future Directions
November 12, 2016 | Capital Hilton | Washington, DC
MedStar Health / SiTEL
3007 Tilden Ave, NW
Suite 3N
Washington, DC 20008
For more information and to register, please visit http://cme.medstarwashington.org/LungCancer
LUNG CANCER 2016: Progress and Future Directions
November 12, 2016 | Capital Hilton | Washington, DC
Course Directors:
Deepa S. Subramaniam, MD, MSc
Georgetown Lombardi Comprehensive Cancer Center
MedStar Georgetown University Hospital
Washington, DC
Giuseppe Giaccone, MD, PhD
MedStar Georgetown Cancer Network
Georgetown Lombardi Comprehensive Cancer Center
MedStar Georgetown University Hospital
Washington, DC
Faculty
COURSE DIRECTORS
FACULTY
Deepa S. Subramaniam, MD, MSc
Eric D. Anderson, MD
Director, Multidisciplinary Thoracic Oncology Clinic
Full Member, Clinical & Experimental Therapeutics Program
Georgetown Lombardi Comprehensive Cancer Center
MedStar Georgetown University Hospital
Washington, DC
Giuseppe Giaccone, MD, PhD
Director, Clinical Research
MedStar Georgetown Cancer Network
Associate Director, Clinical Research
Georgetown Lombardi Comprehensive Cancer Center
MedStar Georgetown University Hospital
Washington, DC
Director, Interventional Pulmonology
MedStar Georgetown University Hospital
Washington, DC
Mark M. Awad, MD, PhD
Thoracic Oncologist
Dana-Farber Cancer Institute
Instructor in Medicine
Harvard Medical School
Boston, MA
Claudia I. Henschke, MD, PhD
Director, Early Lung and Cardiac Action Program
Mount Sinai Hospital
Professor of Radiology
The Mount Sinai Health System
New York, NY
Stephen V. Liu, MD
Geoffrey T. Gibney, MD
Co-Leader, Melanoma Disease Group
Georgetown Lombardi Comprehensive Cancer Center
MedStar Georgetown University Hospital
Washington, DC
Russell K. Hales, MD
Director, Thoracic Oncology Multidisciplinary Clinic
Johns Hopkins Medicine
Assistant Professor, Radiation Oncology and Molecular
Radiation Sciences
Johns Hopkins University
Baltimore, MD
Thoracic Medical Oncologist
Georgetown Lombardi Comprehensive Cancer Center
MedStar Georgetown University Hospital
Assistant Professor of Medicine
Georgetown University Medical Center
Washington, DC
Charles B. Simone, II, MD
Medical Director, Maryland Proton Treatment Center
University of Maryland Medical Center
Associate Professor, Department of Radiation Oncology
University of Maryland School of Medicine
Baltimore, MD
Thomas J. Watson, MD
Regional Chief, MedStar Washington Integrated
Surgery Service
MedStar Georgetown University Hospital
MedStar Washington Hospital Center
Washington, DC
Agenda
7:15 AM
8:00 AM
Registration and Breakfast
Welcome Remarks
Deepa S. Subramaniam, MD, MSc
SESSION II: LOCAL THERAPIES IN THE MANAGEMENT
1:15 PM
Moderator: Stephen V. Liu, MD
1:35 PM
Management of ALK-Positive Lung Cancer
Deepa S. Subramaniam, MD, MSc
OF LUNG CANCER
10:25 AM
Case Presentation
8:15 AM
KEYNOTE ADDRESS: Navigating the
Expanding Landscape in Thoracic Oncology
10:35 AM
Lung SABR: Evolving Indications in Early
Giuseppe Giaccone, MD, PhD
and Advanced Disease
Russell K. Hales, MD
SESSION I: DIAGNOSIS AND PREVENTION
Moderator: Eric D. Anderson, MD
8:35 AM
Case Presentation
8:45 AM
The Latest Updates in CT Screening for
Lung Cancer
Claudia I. Henschke, MD, PhD
10:55 AM
The Role of Proton Beam Therapy in
Thoracic Oncology
Charles B. Simone, II, MD
11:15 AM
Controversies in the Surgical Management
of Lung Cancer
Thomas J. Watson, MD
9:05 AM
Evolving Role of Liquid Tumor Biopsies
Mark M. Awad, MD, PhD
11:35 AM
Panel Discussion
Moderator: Stephen V. Liu, MD
Panelists: R. Hales, C. Simone, T. Watson
9:25 AM
Smoking Cessation
Eric D. Anderson, MD
11:55 AM
Lunch
9:45 AM
Panel Discussion
Moderator: Eric D. Anderson, MD
Panelists: M. Awad, C. Henschke
SESSION III: SYSTEMIC THERAPIES IN THE
10:05 AM
Break
MANAGEMENT OF LUNG CANCER
Moderator: Deepa S. Subramaniam, MD, MSc
12:45 PM
Case Presentation
12:55 PM
Clinical Update on Immune-Oncology
in NSCLC
Stephen V. Liu, MD
1:55 PM
Panel Discussion
Moderator: Deepa S. Subramaniam, MD, MSc
Panelists: G. Giaccone, S. Liu
SESSION IV: SPECIAL TOPICS IN THORACIC ONCOLOGY
Moderator: Giuseppe Giaccone, MD, PhD
2:15 PM
Case Presentation
2:25 PM
Managing Toxicities Associated with
Immunotherapeutics
Geoffrey T. Gibney, MD
2:45 PM
Management of Brain/Leptomeningeal
Metastases in NSCLC Patients
Deepa S. Subramaniam, MD, MSc
3:05 PM
Management of NSCLC Patients with
Rare Mutations
Stephen V. Liu, MD
3:25 PM
Panel Discussion
Moderator: Giuseppe Giaccone, MD, PhD
Panelists: G. Gibney, D. Subramaniam, S. Liu
3:45 PM
Closing Remarks
Giuseppe Giaccone, MD, PhD
3:55 PM
Adjourn
Registration Information
Venue Information
REGISTRATION FEES
CAPITAL HILTON
1001 16th Street, NW
Washington, DC 20036
202-393-1000
Physician..........................................................$200
Resident/Fellow.................................................$35
Advanced Practice Clinician.............................$100
Nurse................................................................$100
Allied Health Professional.................................$100
Updates in EGFR-Mutant NSCLC
Giuseppe Giaccone, MD, PhD
ONLINE REGISTRATION PREFERRED
Please visit our secure website at http://cme.medstarwashington.org/LungCancer for
updated program and registration information. We are unable to accept registrations
or cancellations by telephone. If you wish to pay your registration fee by check, please
download and print a registration form and mail it to the address on the registration
form with your check.
All registrations will be confirmed by email only. Please use an email address that
you check regularly. If you have questions regarding registration or do not receive an
email confirmation of your registration within 1-2 business days, please contact us at
[email protected] or 202-780-1656.
CANCELLATION POLICY
Cancellations made in writing by September 28, 2016 will be subject to a 50%
penalty. No refunds will be given after September 28, 2016. Cancellations will not be
accepted by telephone. In the unlikely event that the course is canceled, we will refund
the registration fee, but are not responsible for any travel costs. Please call 202-7801656 or email [email protected] if you any questions or need any additional
information.
SPECIAL ASSISTANCE
MedStar Georgetown University Hospital and Georgetown Lombardi Comprehensive
Cancer Center wish to ensure that no individual with a disability is excluded, denied
services, segregated or otherwise treated differently from other individuals because of
the absence of auxiliary aids or services identified in the Americans with Disabilities Act.
Please contact 202-780-1656 to notify us of your needs.